BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 23014629)

  • 1. Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF.
    Ehrlich S; Williams PL; Missmer SA; Flaws JA; Ye X; Calafat AM; Petrozza JC; Wright D; Hauser R
    Hum Reprod; 2012 Dec; 27(12):3583-92. PubMed ID: 23014629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary bisphenol A concentrations and association with in vitro fertilization outcomes among women from a fertility clinic.
    Mínguez-Alarcón L; Gaskins AJ; Chiu YH; Williams PL; Ehrlich S; Chavarro JE; Petrozza JC; Ford JB; Calafat AM; Hauser R;
    Hum Reprod; 2015 Sep; 30(9):2120-8. PubMed ID: 26209788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bisphenol A concentrations and ovarian response among women undergoing IVF.
    Mok-Lin E; Ehrlich S; Williams PL; Petrozza J; Wright DL; Calafat AM; Ye X; Hauser R
    Int J Androl; 2010 Apr; 33(2):385-93. PubMed ID: 20002217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary concentrations of bisphenol A, parabens and phthalate metabolite mixtures in relation to reproductive success among women undergoing in vitro fertilization.
    Mínguez-Alarcón L; Messerlian C; Bellavia A; Gaskins AJ; Chiu YH; Ford JB; Azevedo AR; Petrozza JC; Calafat AM; Hauser R; Williams PL;
    Environ Int; 2019 May; 126():355-362. PubMed ID: 30826614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment.
    Wu H; Ashcraft L; Whitcomb BW; Rahil T; Tougias E; Sites CK; Pilsner JR
    Hum Reprod; 2017 Jan; 32(1):65-75. PubMed ID: 27927842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis.
    Upson K; Sathyanarayana S; De Roos AJ; Koch HM; Scholes D; Holt VL
    Hum Reprod; 2014 Nov; 29(11):2457-64. PubMed ID: 25205760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of sleep characteristics with outcomes of IVF/ICSI treatment: a prospective cohort study.
    Yao QY; Yuan XQ; Liu C; Du YY; Yao YC; Wu LJ; Jiang HH; Deng TR; Guo N; Deng YL; Zeng Q; Li YF
    Hum Reprod; 2022 May; 37(6):1297-1310. PubMed ID: 35259255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphenol-A and human oocyte maturation in vitro.
    Machtinger R; Combelles CM; Missmer SA; Correia KF; Williams P; Hauser R; Racowsky C
    Hum Reprod; 2013 Oct; 28(10):2735-45. PubMed ID: 23904465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization.
    Ehrlich S; Williams PL; Missmer SA; Flaws JA; Berry KF; Calafat AM; Ye X; Petrozza JC; Wright D; Hauser R
    Environ Health Perspect; 2012 Jul; 120(7):978-83. PubMed ID: 22484414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
    Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
    Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bisphenol A concentrations and in vitro fertilization outcomes among women from a fertility clinic.
    Radwan P; Wielgomas B; Radwan M; Krasiński R; Klimowska A; Kaleta D; Jurewicz J
    Reprod Toxicol; 2020 Sep; 96():216-220. PubMed ID: 32721521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and paternal preconception exposure to bisphenols and size at birth.
    Mustieles V; Williams PL; Fernandez MF; Mínguez-Alarcón L; Ford JB; Calafat AM; Hauser R; Messerlian C;
    Hum Reprod; 2018 Aug; 33(8):1528-1537. PubMed ID: 29982563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dydrogesterone and 20α-dihydrodydrogesterone plasma levels on day of embryo transfer and clinical outcome in an anovulatory programmed frozen-thawed embryo transfer cycle: a prospective cohort study.
    Neumann K; Masuch A; Vonthein R; Depenbusch M; Schultze-Mosgau A; Eggersmann TK; Griesinger G
    Hum Reprod; 2022 May; 37(6):1183-1193. PubMed ID: 35323905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
    Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and follicular fluid metabolome and markers of ovarian stimulation.
    Hood RB; Liang D; Tan Y; Ford JB; Souter I; Chavarro JE; Jones DP; Hauser R; Gaskins AJ
    Hum Reprod; 2023 Nov; 38(11):2196-2207. PubMed ID: 37740688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N; Bogstad JW; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
    Hum Reprod; 2023 Sep; 38(9):1807-1815. PubMed ID: 37354554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ICSI-related procedural timings and operators on the outcome.
    Maggiulli R; Cimadomo D; Fabozzi G; Papini L; Dovere L; Ubaldi FM; Rienzi L
    Hum Reprod; 2020 Jan; 35(1):32-43. PubMed ID: 31916573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial.
    Zhang S; Tang Y; Wang X; Zong Y; Li X; Cai S; Ma H; Guo H; Song J; Lin G; Lu G; Gong F
    Hum Reprod; 2022 Jun; 37(7):1431-1439. PubMed ID: 35460400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.